Low- and middle-income (LMIC) countries are expected to bear the greatest consequences of the spread of antimicrobial resistance (AMR). The UK AMR Review estimated that by 2050, up to 90% of all deaths related to AMR will be from Africa and Asia. The BALANCE study compares the health and economic impacts of AMR in low-and-middle-income countries with that of high-income countries. With collaborations in Bangladesh, Kenya, Nigeria, Pakistan, Sierra Leone, Turkey, Italy, and Poland, the study integrates high-quality demographic, socioeconomic, epidemiological, clinical, microbiology and genomic data through a capacity-building approach.
https://www.ineosoxford.ox.ac.uk/global-surveillance-amr
